Navigation Links
DrugRisk Update: Court Issues Latest Decision in Pradaxa Bleeding Litigation
Date:8/9/2013

Chicago, IL (PRWEB) August 09, 2013

The prescription drug resource center DrugRisk.com is announcing updated information for patients taking the blood thinner Pradaxa. A federal court overseeing more than 1,000 lawsuits alleging the drug caused internal bleeding recently denied an attempt by the maker of the drug to dismiss a case*.

DrugRisk provides patients taking popular prescription drugs with the latest warnings, recalls, studies and legal news to improve safety and awareness. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Pradaxa is a blood thinner approved by the FDA in 2010 as a stroke preventative for patients with atrial fibrillation. Experts disagree, however, about its risks for internal bleeding. The FDA has advised Pradaxa is no more dangerous than traditional blood thinner warfarin**.

Others, like the Institute for Safe Medication Practices, have warned that patients may be nearly 5 times as likely to die from bleeding with Pradaxa than that from warfarin***. DrugRisk has also added a recent study from the Netherlands which suggests patients taking newer blood thinners like Pradaxa may be 55% more likely to suffer internal bleeding****.

So far, more than 1,133 patients have filed a Pradaxa lawsuit alleging internal bleeding, with cases now consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, DrugRisk has learned that Judge David Herndon, who is overseeing the cases, recently blocked attempts by drug maker Boehringer Ingelheim to dismiss a case in which a man alleges Pradaxa caused him internal bleeding injury*.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugRisk.com or speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugRisk.com today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*Judge David Herndon, 7/18/13; aboutlawsuits.com/wp-content/uploads/2013-07-18-Jackson-Order.pdf
**FDA, 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****Gastroenterology, July 2013; gastrojournal.org/article/S0016-5085(13)00290-4/fulltext
*****Judge David Herndon, 7/18/13; aboutlawsuits.com/wp-content/uploads/2013-07-18-Jackson-Order.pdf

Read the full story at http://www.prweb.com/releases/pradaxa-bleeding/litigation-news/prweb11012356.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: New Study Warns of Pradaxa Dangers as Lawsuits Increase
2. DrugRisk Update: Panel To Decide Fate of Januvia Lawsuits Next Week
3. DrugRisk Announces Latest Ruling By Judicial Panel on NuvaRing Lawsuits
4. DrugRisk Announces Drop in Yaz Lawsuits As Bayer Commits $1.5 Billion to Settlements
5. DrugRisks Announces Yaz Center With Latest Updates on Blood Clot Warnings and Settlements
6. DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
7. DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits
8. Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes
9. DrugRisk News: Federal Panel Issues Latest Mirena Lawsuit Updates
10. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
11. DrugRisks Update: Yaz Class Action Begins in Canada as Settlements Continue in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's ... President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. ... 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, the ... by Walgreens and pharmacy benefit manager Prime Therapeutics LLC ... brand, which included the unveiling of new signage at ... as well as at a few other company-owned facilities ... brand to patients, some of whom will begin to ...
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
Breaking Medicine Technology: